Manufacturing News of Note—Olon starts new facility; Hikma signs on with Civic Rx

stocks
(Pixabay)

> Italy-based CDMO Olon has started construction of new manufacturing facility at its microbial CDMO facility located in Capua, Italy. Release

> Hikma Pharmaceuticals has become the latest CDMO to sign a deal with Civica Rx, the hospital-controlled company that is helping healthcare providers get drugs that are often in short supply. Release

> WuXi STA says its Analytical Service Unit in Shanghai and active pharmaceutical ingredient process R&D and manufacturing facility in Changzhou both successfully passed two inspections from the U.S. FDA. Release

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> The CPhI and P-MEC China trade show in China saw record numbers, reflecting the surge of interest in manufacturing products in that country. Release 

 

 

Suggested Articles

Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin. 

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.